In patients with acute respiratory distress syndrome (ARDS), which of the following statements about prone positioning are true: (1) its main benefit is redistribution of pulmonary blood flow toward better‑ventilated lung regions; (2) the PROSEVA trial demonstrated a mortality benefit with prone sessions of at least 16 hours per day; (3) prone positioning eliminates intrapulmonary shunt entirely; (4) it is relatively contraindicated in an open abdomen or unstable spine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Prone Positioning in ARDS: Statement Analysis

Statement 2 is correct—the PROSEVA trial demonstrated a mortality benefit with prone sessions of at least 16 hours per day, and statement 4 is correct—open abdomen and unstable spine are relative contraindications to prone positioning. 1

Detailed Analysis of Each Statement

Statement 1: Main benefit from redistributing pulmonary blood flow (INCORRECT)

This statement misidentifies the primary mechanism. The main benefit of prone positioning comes from more homogeneous distribution of ventilation and reduction in ventilator-induced lung injury, not primarily from blood flow redistribution. 2, 3

The actual physiological mechanisms include:

  • More even distribution of gas-tissue ratios along the dependent-nondependent axis
  • Reduced overdistension in non-dependent (ventral) lung regions
  • Decreased cyclical opening and closing in dependent (dorsal) lung regions
  • Recruitment of well-perfused dorsal regions
  • More homogeneous distribution of lung stress and strain 2, 3

While blood flow redistribution does occur and contributes to improved ventilation-perfusion matching, it is not the primary mechanism driving the mortality benefit.

Statement 2: PROSEVA trial and 16-hour sessions (CORRECT)

This statement is accurate. The 2024 Intensive Care Medicine guidelines explicitly recommend prone positioning for at least 12 hours, preferably 16 hours per day 1. The PROSEVA trial specifically demonstrated that prone positioning applied for at least 16 hours per day in patients with ARDS and PaO₂/FiO₂ <150 mmHg significantly reduced 28-day mortality from 32.8% in the supine group to 16% in the prone group 1.

Meta-analyses confirm that:

  • Minimum duration of 12 hours is necessary for mortality benefit
  • Each additional hour improves the effect 1
  • Periods longer than 16 hours have not been studied 1

Statement 3: Eliminates intrapulmonary shunt entirely (INCORRECT)

This is false—prone positioning reduces but does not eliminate intrapulmonary shunt. The evidence shows prone positioning leads to:

  • Reduction in alveolar shunt (not elimination)
  • Better ventilation/perfusion matching
  • Decreased calculated venous admixture (Qva/Qt) 2, 4

Approximately 57% of patients respond to prone positioning with improved oxygenation 4, meaning a substantial proportion do not respond at all. If prone positioning eliminated shunt entirely, the response rate would be universal.

Statement 4: Relative contraindications (CORRECT)

Open abdomen and unstable spine are indeed relative contraindications. The 2024 guidelines explicitly state that prone positioning should only be carried out in individual cases after considering risks and benefits in an interdisciplinary fashion when the following contraindications exist 1:

  • Open abdomen
  • Spinal instability
  • Increased intracranial pressure
  • Cardiac arrhythmias with hemodynamic consequences
  • Shock

The 2017 Critical Care guideline similarly lists open abdominal wound and unstable spinal lesions as contraindications 2. Note these are relative, not absolute contraindications—the only absolute contraindication is unstable spinal fracture 3.

Important Clinical Caveats

For open abdomen specifically: The guidelines suggest considering prone positioning in patients following abdominal surgery after individual consideration of benefits (improvement in oxygenation) versus risks (increase in intraabdominal pressure with risk of surgical complication, acute renal failure, or hypoxic hepatitis) 1.

Common pitfall: Delaying prone positioning due to perceived contraindications. The evidence strongly supports early implementation when indicated (PaO₂/FiO₂ <150 mmHg), ideally within 48 hours of mechanical ventilation initiation 1.

References

Related Questions

When is neuromuscular relaxation and blockade indicated in acute respiratory distress syndrome (ARDS)?
What is the importance of prone positioning in adult patients with moderate to severe hypoxemic respiratory failure (PaO₂/FiO₂ ≤150 mm Hg) receiving invasive mechanical ventilation?
In a patient with severe acute respiratory distress syndrome on day 10 who has been kept supine, should I initiate an airway pressure release ventilation (APRV) trial with spontaneous breathing?
What is the ARDSnet protocol for initiating BiPAP (bilevel positive airway pressure) in an adult patient with acute respiratory distress syndrome?
When should prone positioning be started, and what are the key steps for its implementation in an adult with moderate-to-severe acute respiratory distress syndrome on invasive mechanical ventilation?
Can benztropine (Cogentin) cause myoclonus?
What physical therapy is recommended for a 33-year-old man with acute non‑radiating low back pain of 5 days duration, a negative straight‑leg‑raise test, and a prolonged 10‑hour sitting work schedule?
A 3‑month‑19‑day‑old breast‑fed infant presenting with brownish (coffee‑colored) vomiting 6–7 times today and for the past two days, otherwise well, drinking well, with moist mucous membranes, what are the possible causes and recommended management?
What is the appropriate third‑line therapy for a fit 58‑year‑old patient with follicular lymphoma who relapsed 5–6 years after completing rituximab + lenalidomide (R2) in the INMIND trial, without histologic transformation?
What is the intramuscular dose of ceftriaxone (Rocephin) for acute otitis media in the clinic?
Can calcium and vitamin D supplementation be initiated in a 24-year-old patient with low bone mass on DEXA and low fracture risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.